Genomic Study in Non-small Cell Lung Cancer Brain Metastasis

A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis

NCT02803619 ·Status: UNKNOWN

Circulating Tumor DNA and T Cell Repertoire Predict Radiotherapeutic Outcomes in NSCLC Patients With Brain Metastasis

NCT05737589 ·Status: UNKNOWN

The Establishment and Clinical Application of a Prediction Model of Lung Cancer Distant Metastasis Based on the Genomic Characteristics of Circulating Tumor Cells

NCT04568720 ·Status: UNKNOWN

Correlation Between EGFR Mutation Using cfDNAs and Circulating Tumor Cells in Patients With NSCLC

NCT02422628 ·Status: UNKNOWN

Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions and Differentiating Multiple Primary Lung Cancer From Intrapulmonary Metastases of Non-small Cell Lung Cancer

NCT03679936 ·Status: UNKNOWN

Prophylactic Cranial Irradiation Versus Observation in Stage IV NSCLC Randomized Controlled Clinical Study

NCT06014450 ·Status: UNKNOWN ·Phase: NA

Gene Mutations in Non-Small Cell Lung Cancer Cells

NCT00977509 ·Status: UNKNOWN

The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer

NCT06483919 ·Status: ACTIVE_NOT_RECRUITING

Multimodal Large Model-Driven Risk and Prognosis Assessment for Brain Metastases in Lung Cancer

NCT07107035 ·Status: NOT_YET_RECRUITING

Non-small Cell Lung Cancer With Central Nervous System Metastasis

NCT06026735 ·Status: RECRUITING

A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments

NCT06617390 ·Status: COMPLETED

PD-L1 Expression on CTCs in HNSCC Patients Underwent Curative CCRT

NCT05008796 ·Status: UNKNOWN

Detection Cell Free DNA in Lung Cancer Patients

NCT02738593 ·Status: UNKNOWN

Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of Treatment

NCT06557967 ·Status: COMPLETED

Pathological and Nuclear Medicine Factors for Prognosis in Lung Carcinoma

NCT04276025 ·Status: COMPLETED

A Real-world Study to Explore Recurrence/Metastases of the NSCLC Patients and the Impact Factors of Patient Survivals

NCT03710616 ·Status: UNKNOWN

Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLC

NCT07186855 ·Status: COMPLETED

To Evaluate the Correlation Between the Results of Specific Gene Testing and the Efficacy of Targeted Therapy in Patients With NSCLC

NCT05805267 ·Status: COMPLETED

Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in China

NCT02458651 ·Status: COMPLETED

Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Associated With Chinese Patients With Advanced Lung Cancer

NCT03505515 ·Status: COMPLETED

ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage II to IIIA NSCLC by NGS

NCT03465241 ·Status: COMPLETED

The Use of Molecular Radiogenomics in Non-small Cell Lung Cancer

NCT05541744 ·Status: RECRUITING

Methylation Status of CD44 Promoter Region in Primary Lung Cancer

NCT00173680 ·Status: UNKNOWN

Brain Metabolic Network of PET in Patients With Advanced Non-Small Cell Lung Cancer

NCT05380908 ·Status: COMPLETED

Gene-expression Profiles in CNS-metastatic Non-small Cell Lung Cancer

NCT00862173 ·Status: UNKNOWN